Evidence map›Paper›PMID 34423792›Full record

ArticleJCI insight2021

Arf6 exacerbates allergic asthma through cell-to-cell transmission of ASC inflammasomes.

SangJoon Lee, Akari Ishitsuka, Takahiro Kuroki, Yu-Hsien Lin, Akira Shibuya, Tsunaki Hongu, Yuji Funakoshi, Yasunori Kanaho, Kyosuke Nagata, Atsushi Kawaguchi

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Targeting MicroRNA-485-3p Blocks Alzheimer's Disease Progression.International journal of molecular sciences · 2021
    Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 4 countries.

SangJoon LeeDepartment of Infection Biology, Faculty of Medicine.
Akari IshitsukaPhD Program in Human Biology, School of Integrative and Global Majors.
Takahiro KurokiGraduate School of Comprehensive Human Sciences.
Yu-Hsien LinDepartment of Immunology, Faculty of Medicine.
Akira ShibuyaDepartment of Immunology, Faculty of Medicine.
Tsunaki HonguDepartment of Physiological Chemistry, Faculty of Medicine.
Yuji FunakoshiDepartment of Physiological Chemistry, Faculty of Medicine.
Yasunori KanahoDepartment of Physiological Chemistry, Faculty of Medicine.
Kyosuke NagataDepartment of Infection Biology, Faculty of Medicine.
Atsushi KawaguchiDepartment of Infection Biology, Faculty of Medicine.
Physiological Society · GBBiology of Infection · FRUniversity of Tsukuba · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Asthma is a chronic inflammatory disease of the airways associated with excess production of Th2 cytokines and lung eosinophil accumulation. This inflammatory response persists in spite of steroid administration that blocks autocrine/paracrine loops of inflammatory cytokines, and the detailed mechanisms underlying asthma exacerbation remain unclear. Here, we show that asthma exacerbation is triggered by airway macrophages through a prion-like cell-to-cell transmission of extracellular particulates, including ASC protein, that assemble inflammasomes and mediate IL-1β production. OVA-induced allergic asthma and associated IL-1β production were alleviated in mice with small GTPase Arf6-deficient macrophages. The extracellular ASC specks were slightly engulfed by Arf6-/- macrophages, and the IL-1β production was reduced in Arf6-/- macrophages compared with that in WT macrophages. Furthermore, pharmacological inhibition of the Arf6 guanine nucleotide exchange factor suppressed asthma-like allergic inflammation in OVA-challenged WT mice. Collectively, the Arf6-dependent intercellular transmission of extracellular ASC specks contributes to the amplification of allergic inflammation and subsequent asthma exacerbation.

Indexed as

ADP-Ribosylation Factor 6AnimalsAsthmaCARD Signaling Adaptor ProteinsCell CommunicationDisease Models, AnimalHumansInflammasomesInterleukin-1betaLungMacrophages, AlveolarMiceMice, KnockoutOvalbuminPhagocytosisSymptom Flare UpADP-Ribosylation Factor 6Arf6 protein, mouseCARD Signaling Adaptor ProteinsIL1B protein, mouseInflammasomesInterleukin-1betaOvalbuminPYCARD protein, humanPycard protein, mouseSecinH3TriazolesAsthmaInflammation

Identifiers

PMID34423792
PMCPMC8410019
OpenAlexW3195569198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.